https://stock.noler.com/us/stock/acura-pharmaceuticals-inc https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/accounts-receivable-net https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/accrual-for-taxes-other-than-income-taxes-current https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/accrued-investment-income-receivable https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/accumulated-amortization-deferred-finance-costs https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/amended-reports-10-k https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/amended-reports-10-q https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/amortization https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/amortization-of-acquisition-costs https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/aoci https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/asset-impairment-charges https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/available-for-sale-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/available-for-sale-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/available-for-sale-amortized-cost https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/available-for-sale-debt-maturities-after-one-through-five-years-fair-value https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/available-for-sale-debt-maturities-within-one-year-fair-value https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/available-for-sale-gross-unrealized-gain https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/available-for-sale-gross-unrealized-gains https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/available-for-sale-gross-unrealized-loss https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/available-for-sale-gross-unrealized-losses https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/cash https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/clinical-trials https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/comprehensive-income https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/cost-of-goods-sold https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/cost-of-revenue https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/costs-and-expenses https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/cumulative-effect-of-new-accounting-principle-in-period-of-adoption https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/damages-sought-value https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/debt-basis-spread-on-variable-rate https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/debt-carrying-amount https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/debt-default-longterm-debt-amount https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/debt-face-amount https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/debt-fee-amount https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/debt-increase-accrued-interest https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/debt-interest-rate-effective-percentage https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/debt-issuance-costs https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/debt-issued https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/debt-maturing-after-year-five https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/debt-periodic-payment https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/debt-periodic-payment-principal https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/debt-related-commitment-fees-and-debt-issuance-costs https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/debt-repurchase-amount https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/debt-unamortized-discount https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/deferred-compensation-arrangement-with-individual-recorded-liability https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/deferred-costs-current-and-noncurrent https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/deferred-finance-costs-noncurrent-net https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/deferred-revenue https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/deferred-revenue-2 https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/deferred-revenue-revenue-recognized https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/deferred-sales-inducements-additions https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/deferred-tax-assets-gross-current https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/deferred-tax-liabilities-leasing-arrangements https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/deposits-assets-current https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/depreciation https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/depreciation-and-amortization https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/due-from-related-parties-current https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/due-to-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/due-to-related-parties-noncurrent https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/eps https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/federal-income-tax-expense-benefit https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/fifo-inventory-amount https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/finance-lease-interest-payment-on-liability https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/finance-lease-liability https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/finance-lease-liability-current https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/finance-lease-liability-noncurrent https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/finance-lease-liability-payments-due https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/finance-lease-liability-payments-due-next-twelve-months https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/finance-lease-liability-payments-due-year-two https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/finance-lease-principal-payments https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/finance-lease-right-of-use-asset https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/finance-lease-right-of-use-asset-amortization https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/form-d-other https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/gain-contingency-unrecorded-amount https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/income-taxes-paid https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/income-taxes-paid-2 https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/income-taxes-receivable https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/income-taxes-receivable-noncurrent https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/increase-decrease-in-accrued-interest-receivable-net https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/increase-decrease-in-accrued-investment-income-receivable https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/increase-decrease-in-deferred-income-taxes https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/increase-decrease-in-due-from-related-parties https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/increase-decrease-in-finished-goods-and-work-in-process-inventories https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/increase-decrease-in-income-taxes-receivable https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/increase-decrease-in-interest-payable-net https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/increase-decrease-in-other-current-liabilities https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/increase-decrease-in-other-operating-capital-net https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/increase-decrease-in-receivables https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/insider-transactions-other https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/insider-transactions-preferred https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/insider-transactions-warrants https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/interest-expense-on-debt https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/interest-expense-related-party https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/interest-income-related-party https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/interest-paid https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/interest-paid-net https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/interest-payable-current https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/inventory https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/inventory-adjustments https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/inventory-finished-goods https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/inventory-gross https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/inventory-raw-materials-and-supplies https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/inventory-valuation-reserves https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/inventory-write-down https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/investment-income-interest https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/investment-income-nonoperating https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/license-and-services-revenue https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/licenses-revenue https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/long-term-debt https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/marketable-securities https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/marketable-securities-current https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/marketable-securities-gain-loss https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/new-accounting-pronouncement-or-change-in-accounting-principle-cumulative-effect-of-change-on-equity-or-net-assets https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/notes-payable-related-parties-classified-current https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/number-of-operating-segments https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/oci-net-of-tax https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/oci-net-of-tax-2 https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/operating-loss-carryforwards-valuation-allowance https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/other-assets https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/other-current-liabilities https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/other-income https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/other-inventory https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/other-liabilities https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/other-nonoperating-expense https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/other-sales-revenue-net https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/patents-active https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/patents-pending https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/prepaid-insurance https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/pretax-income https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/principal-transactions-revenue https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/proceeds-from-collaborators https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/proceeds-from-license-fees-received https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/proceeds-from-other-equity https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/proceeds-from-repayments-of-notes-payable https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/proceeds-from-sale-and-maturity-of-other-investments https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/proceeds-from-short-term-debt https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/product-warranty-accrual-additions-from-business-acquisition https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/professional-and-contract-services-expense https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/profit-loss https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/receivables-net-current https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/reimbursement-revenue https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/related-parties-amount-in-cost-of-sales https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/repayments-of-debt https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/repayments-of-lines-of-credit https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/research-and-development-arrangement-contract-to-perform-for-others-compensation-earned https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/research-and-development-arrangement-contract-to-perform-for-others-costs-incurred-gross https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/restricted-cash-and-investments https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/retail-related-inventory https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/revenue https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/revenue-recognition-milestone-method-revenue-recognized https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/revenue-recognition-sales-returns-reserve-for-sales-returns https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/royalty-revenue https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/sale-leaseback-transaction-net-proceeds-financing-activities https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/sale-leaseback-transaction-transaction-costs-financing-activities https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/sale-of-stock-consideration-received-on-transaction https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/sales-revenue-services-net https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/sec-filings-10-k https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/sec-filings-10-k405 https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/sec-filings-10-q https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/sec-filings-25-nse https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/sec-filings-8-k https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/sec-filings-ars https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/sec-filings-certnas https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/sec-filings-ct-order https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/sec-filings-def-14a https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/sec-filings-defa14a https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/sec-filings-defr14a https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/sec-filings-prem14a https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/sec-filings-prer14a https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/sec-filings-regdex https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/secondary-offerings-form-424b2 https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/secondary-offerings-form-rw https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/secured-debt https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/sga-expense https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/share-price https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/shares-issued-value-restricted-stock-award-gross https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/shares-paid-for-tax-withholding-for-share-based-compensation https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/short-term-borrowings https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-award-rsu-forfeited-in-period https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-award-rsu-forfeitures-grant-date-fair-value https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-award-rsu-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-award-rsu-vested-in-period-grant-date-fair-value https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-issued-shares-issued-for-acquisitions https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/tax-credit-carryforward-amount https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/tax-reconciliation-other-reconciling-items https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/tax-withholding-on-stock-awards https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/total-long-term-debt https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/unrealized-gain-loss-on-securities https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/utilities-operating-expense-depreciation-and-amortization https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/weighted-average-number-of-shares-issued-basic https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/weighted-average-number-of-shares-restricted-stock https://stock.noler.com/us/stock/acura-pharmaceuticals-inc/write-off-of-deferred-debt-issuance-cost